Editas Medicine Names Bruce E. Eaton, Ph.D., as Executive Vice President and Chief Business Officer
July 26, 2021 09:00 ET | Source: Editas Medicine, Inc. Editas Medicine, Inc. Cambridge, Massachusetts, UNITED STATES
Dr. Eaton joined the Company in 2018 and brings more than 30 years of experience to the role
CAMBRIDGE, Mass., July 26, 2021 (GLOBE NEWSWIRE) Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that Bruce E. Eaton, Ph.D., has been promoted to Executive Vice President and Chief Business Officer. In his new role, Dr. Eaton oversees the Company’s corporate strategy, business development, and alliance management.
“I am thrilled to announce the promotion of Bruce to Executive Vice President and Chief Business Officer. Bruce has been a vital member of our team for many years, driving performance and demonstrating extraordinary leadership. With his deep knowledge of our Company
SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
RareStone Inc Announces Strategic Collaboration with Tencent on a Service Ecosystem Focused on Rare Disease Patients in China
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
RARE-X Appoints Charlene Son Rigby as Chief Executive Officer
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Benchmark Research Announces New Organizational Structure and Advisory Board
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.